Grünenthal: driving innovative treatments in pain and beyond through collaboration and partnerships

In 2017 Grünenthal generated global revenues of €1.3 billion and signed around 50 partnering deals, positioning it as one of the leading companies to partner with for the development of pain therapeutics

Like Comment
Page of
Go to the profile of Grunenthal


Our purpose is to change lives for the better. We believe that change is possible. We invest heavily in innovation, exploring new possibilities to develop smart solutions. Success comes from pioneering treatments that transform patients’ lives for the better. This measure of success drives everything we do.

No comments yet.